المؤلفون: Méndez-Vidal MJ; Medical Oncology Department, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain. mariajose.mendezvidal@gmail.com., Lázaro Quintela M; Medical Oncology Department, Hospital Alvaro Cunqueiro-Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain., Lainez-Milagro N; Medical Oncology Department, Hospital Universitario de Navarra (HUN), Pamplona, Spain., Perez-Valderrama B; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Suárez Rodriguez C; Medical Oncology Department, Hospital Universitario Vall D'Hebron, Barcelona, Spain., Arranz Arija JÁ; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Peláez Fernández I; Medical Oncology Department, Hospital de Cabueñes, Gijón, Spain., Gallardo Díaz E; Medical Oncology Department, Corporació Sanitària Parc Taulì, Barcelona, Spain., Lambea Sorrosal J; Medical Oncology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., González-Del-Alba A; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Sep; Vol. 25 (9), pp. 2732-2748. Date of Electronic Publication: 2023 Aug 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/therapy , Carcinoma, Renal Cell*/drug therapy , Kidney Neoplasms*/therapy , Kidney Neoplasms*/drug therapy, Male ; Humans ; Female ; Sunitinib/adverse effects ; Nivolumab/therapeutic use ; Quality of Life ; Tyrosine/therapeutic use

المؤلفون: Arranz-Herrero J; Transplant Immunology Unit, Microbiology National Center, Instituto de Salud Carlos III, Madrid, Spain; Microbiology Section, Department of Pharmaceutical Science and Health, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Spain; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain., Presa J; Independent researcher, Madrid, Spain., Rius-Rocabert S; Microbiology Section, Department of Pharmaceutical Science and Health, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Spain; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain; CEMBIO (Centre for Metabolomics and Bioanalysis), Pharmacy School, San Pablo CEU University, Madrid, Spain., Utrero-Rico A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA., Arranz-Arija JÁ; Medical Oncology Department, Gregorio Marañón University Hospital, Madrid, Spain., Lalueza A; Internal Medicine Department, Hospital 12 de Octubre, Madrid, Spain., Escribese MM; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain., Ochando J; Transplant Immunology Unit, Microbiology National Center, Instituto de Salud Carlos III, Madrid, Spain; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA., Soriano V; Infectious Diseases Unit, UNIR Health Science School & Medical Center, Madrid, Spain., Nistal-Villan E; Microbiology Section, Department of Pharmaceutical Science and Health, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Spain; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain. Electronic address: estanislao.nistalvillan@ceu.es.

المصدر: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Jun; Vol. 131, pp. 173-179. Date of Electronic Publication: 2023 Apr 07.

نوع المنشور: Meta-Analysis; Systematic Review; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Influenza, Human*/complications , Influenza, Human*/drug therapy , Influenza, Human*/diagnosis , Coinfection*/epidemiology , Influenza A Virus, H1N1 Subtype* , Pneumonia*/epidemiology , Staphylococcal Infections*/epidemiology, Humans ; Staphylococcus aureus ; Streptococcus pneumoniae ; Haemophilus influenzae

المؤلفون: Rodríguez Pérez A; Radiation Oncology Department, Hospital Ruber Internacional, C. de La Masó, 38, 28034, Madrid, Spain. auroraropez@gmail.com., Felip Font E; Medical Oncology Department, Hospital Universitario del Vall d'Hebron, Barcelona, Spain., Chicas-Sett R; Department of Radiation Oncology, ASCIRES Grupo Biomédico, Valencia, Spain., Montero-Luis Á; Radiation Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain., de Paz Arias L; Medical Oncology Department, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain., González-Del-Alba A; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., López-Campos F; Radiation Oncology Department, Hospital Ramón y Cajal, Madrid, Spain., López López C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Hernando Requejo O; Radiation Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain., Conde-Moreno AJ; Radiation Oncology Department, Hospital La Fe, Valencia, Spain., Arranz Arija JÁ; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., de Castro Carpeño J; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Apr; Vol. 25 (4), pp. 882-896. Date of Electronic Publication: 2022 Dec 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Breast Neoplasms*/therapy , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Prostatic Neoplasms* , Radiosurgery*/methods, Male ; Humans ; Medical Oncology

المؤلفون: Ortiz A; Sociedad Española de Nefrología (S.E.N.); Servicio de Nefrología, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain., Quiroga B; Sociedad Española de Nefrología (S.E.N.); Servicio de Nefrología, IIS-La Princesa, Hospital Universitario de la Princesa, Madrid, Spain. Electronic address: borjaqg@gmail.com., Díez J; Sociedad Española de Nefrología (S.E.N.); Center of Applied Medical Research and School of Medicine, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de la Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, Madrid, Spain., Escalada San Martín FJ; Servicio de Endocrinología, Clínica Universidad de Navarra, Pamplona, Spain; Sociedad Española de Endocrinología y Nutrición (SEEN)., Ramirez L; Servicio de Angiología y Cirugía Vascular, Hospital Universitario de la Paz, Madrid, Spain; Sociedad Española de Angióloga y Cirugía Vascular (SEACV)., Pérez Maraver M; Servicio de Endocrinología, Hospital Universitari Bellvitge, Barcelona, Spain; Sociedad Española de Diabetes (SED)., Martínez-Berganza Asensio ML; Centro de Salud Ensanche de Vallecas, Madrid, Spain; Sociedad Española de Médicos de Atención Primaria (SEMERGEN)., Arranz Arija JÁ; Servicio de Oncología, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Sociedad Española de Oncología Médica (SEOM)., Alvarez-Ossorio Fernández JL; Hospital Universitario Puerta del Mar, Cádiz, Spain; Asociación Española de Urología (AEU)., Córdoba R; Servicio de Hematología, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain; Sociedad Española de Hematología y Hemoterapia (SEHH)., Brotons Muntó F; Centro de Salud Trinitat, Valencia, Spain; Sociedad Española de Medicina de Familia y Comunitaria (semFYC)., Cancelo Hidalgo MJ; Servicio de Ginecología y Obstetricia, Hospital Universitario de Guadalajara, Universidad de Alcalá, Guadalajara, Spain; Sociedad Española de Ginecología y Obstetricia (SEGO)., Carles Reverter J; Servicio de Hematología, Hospital Clínic, Barcelona, Spain; Sociedad Española de Trombosis y Hemostasia (SETH)., Plasencia-Rodríguez C; Servicio de Reumatología, Hospital Universitario La Paz, Madrid, Spain; Sociedad Española de Reumatología (SER)., Carretera Gómez J; Servicio de Medicina Interna, Hospital Universitario de Badajoz, Badajoz, Spain; Sociedad Española de Medicina Interna (SEMI)., Guijarro C; Servicio de Medicina Interna, Hospital Universitario Fundación Alcorcón - Universidad Rey Juan-Carlos, Madrid, Spain; Sociedad Española de Arterioesclerosis (SEA)., Freijo Guerrero MDM; Sociedad Española de Nefrología (S.E.N.); Servicio de Neurología, Hospital de Cruces, Baracaldo, Spain; En representación del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología., de Sequera P; Sociedad Española de Nefrología (S.E.N.); Servicio de Nefrología, Hospital Universitario Infanta Leonor, Universidad Complutense De Madrid, Madrid, Spain.

المصدر: Nefrologia [Nefrologia (Engl Ed)] 2023 Mar-Apr; Vol. 43 (2), pp. 245-250. Date of Electronic Publication: 2023 Jul 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier España, Place of publication not identified Country of Publication: Spain NLM ID: 101778581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2013-2514 (Electronic) Linking ISSN: 20132514 NLM ISO Abbreviation: Nefrologia (Engl Ed) Subsets: MEDLINE

مواضيع طبية MeSH: Renal Insufficiency, Chronic*/complications , Renal Insufficiency, Chronic*/diagnosis , Renal Insufficiency, Chronic*/therapy , Vascular Diseases*/diagnosis , Vascular Diseases*/etiology , Vascular Diseases*/prevention & control , Cardiology*, Humans ; Albuminuria/diagnosis ; Societies, Scientific ; Disease Progression ; Creatinine

المؤلفون: Villanueva-Bueno C; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Collado-Borrell R; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Escudero-Vilaplana V; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Revuelta-Herrero JL; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Marzal-Alfaro MB; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., González-Haba E; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Arranz-Arija JÁ; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Osorio S; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Herranz-Alonso A; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Sanjurjo-Saez M; Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

المصدر: Frontiers in public health [Front Public Health] 2022 Nov 04; Vol. 10, pp. 978783. Date of Electronic Publication: 2022 Nov 04 (Print Publication: 2022).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

مواضيع طبية MeSH: Mobile Applications* , Antineoplastic Agents*/therapeutic use , Antineoplastic Agents*/adverse effects , Neoplasms*/drug therapy, Humans ; Female ; Middle Aged ; Male ; Prospective Studies ; Hospitals, University

المؤلفون: Valderrama BP; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Av. Manuel Siurot, s/n, 41013, Sevilla, Spain. bpvalderrama@gmail.com., González-Del-Alba A; Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Morales-Barrera R; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Peláez Fernández I; Medical Oncology Department, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Vázquez S; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Caballero Díaz C; Medical Oncology Department, Hospital General Universitario de Valencia, CIBERONC (Centro de Investigación Biomédica de Red en Cáncer), Valencia, Spain., Domènech M; Medical Oncology Department, Medical Oncology Service, Hospital Fundació Althaia, Manresa, Spain., Fernández Calvo O; Medical Oncology Department, Complejo Hospitalario Universitario, Ourense, Spain., Gómez de Liaño Lista A; Medical Oncology Department, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas, Spain., Arranz Arija JÁ; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Apr; Vol. 24 (4), pp. 613-624. Date of Electronic Publication: 2022 Mar 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/pathology , Urinary Bladder Neoplasms*/pathology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cisplatin/therapeutic use ; Cystectomy ; Humans ; Muscles/pathology ; Neoadjuvant Therapy ; Neoplasm Invasiveness

المؤلفون: Bellmunt Molins J; Medical Oncology, Hospital del Mar, Barcelona, Spain; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: jbellmunt@imim.es., García-Donas Jiménez J; Medical Oncology, HM Hospitales, Centro Integral Oncológico HM Clara Campal, Madrid, Spain., Valderrama BP; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Virizuela Echaburu JA; Medical Oncology, Hospital Universitario Virgen de Macarena, Sevilla, Spain., Hernando-Polo S; Medical Oncology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Climent Durán MÁ; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain., Villa-Guzmán JC; Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Arranz Arija JÁ; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Ostiategui ML; Medical Oncology, Hospital General Universitario de Elda, Alicante, Spain., Milagro NL; Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain., González-Del-Alba A; Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., González BM; Medical Oncology Department, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain., Díaz EG; Oncology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain., Gauna DC; Medical Oncology, CIBER-ONC, Hospital Universitario 12 de Octubre, Madrid, Spain., Santasusana MD; Medical Oncology, Althaia, Xarxa Assitencial de Manresa, Manresa, Spain., Herranz UA; Medical Oncology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain., Del Muro Solans XG; Medical Oncology, Institut Català d'Oncologia Hospitalet, IDIBELL, Universitat de Barcelona, Hospitalet de Llobregat, Spain., Pérez-Gracia JL; Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Vázquez JP; Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Pous AF; Medical Oncology, Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B∙ARGO), IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Dec; Vol. 18 (6), pp. 452-460. Date of Electronic Publication: 2020 May 11.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Transitional Cell*/drug therapy , Urinary Bladder Neoplasms*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Survival Analysis ; Vinblastine/analogs & derivatives ; Vinblastine/therapeutic use

المؤلفون: Amor-García MÁ; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Collado-Borrell R; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Escudero-Vilaplana V; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Melgarejo-Ortuño A; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Herranz-Alonso A; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Arranz Arija JÁ; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Sanjurjo-Sáez M; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

المصدر: JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2020 Jul 23; Vol. 8 (7), pp. e17609. Date of Electronic Publication: 2020 Jul 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: JMIR Publications Inc Country of Publication: Canada NLM ID: 101624439 Publication Model: Electronic Cited Medium: Internet ISSN: 2291-5222 (Electronic) Linking ISSN: 22915222 NLM ISO Abbreviation: JMIR Mhealth Uhealth Subsets: MEDLINE

مواضيع طبية MeSH: Mobile Applications* , Urogenital Neoplasms*/diagnosis , Urogenital Neoplasms*/therapy, Cross-Sectional Studies ; Delivery of Health Care ; Female ; Humans ; Male ; Surveys and Questionnaires

المؤلفون: Climent MÁ; Instituto Valenciano de Oncología, Valencia, Spain. Electronic address: macliment@fivo.org., Pérez-Valderrama B; Medical Oncology Department, Hospital Universitario Virgen Del Rocío, Sevilla, Spain., Mellado B; Medical Oncology Department, IDIBAPS, Hospital Clinic, Universidad de Barcelona, Spain., Fernández Parra EM; Medical Oncology Department, Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain., Fernández Calvo O; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Ochoa de Olza M; Medical Oncology Department, Instituto Catalán de Oncología, Barcelona, Spain., Muinelo Romay L; Liquid Biopsy Analysis Unit, Translational Medical Oncology, Health Research Institute of Santiago de Compostela (IDIS), CIBERONC, Santiago de Compostela, Spain., Anido U; Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Domenech M; Medical Oncology Department, Hospital Althaia, Manresa, Spain., Hernando Polo S; Medical Oncology Department, Hospital Universitario Fundación de Alcorcón, Alcorcón, Spain., Arranz Arija JÁ; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Caballero C; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain., Juan Fita MJ; Instituto Valenciano de Oncología, Valencia, Spain., Castellano D; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Dec; Vol. 87, pp. 30-37. Date of Electronic Publication: 2017 Nov 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prednisone/*administration & dosage , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Taxoids/*administration & dosage, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Disease-Free Survival ; Drug Administration Schedule ; Humans ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplastic Cells, Circulating/drug effects ; Neoplastic Cells, Circulating/pathology ; Prednisone/adverse effects ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology ; Spain ; Taxoids/adverse effects ; Time Factors ; Treatment Outcome

المؤلفون: Arranz Arija JÁ; Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain. jarranza.oncomed@gmail.com, Cassinello Espinosa J, Climent Durán MÁ, Rivero Herrero F

مؤلفون مشاركون: SEOM (Spanish Society of Clinical Oncology)

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2012 Jul; Vol. 14 (7), pp. 520-7.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Practice Guidelines as Topic*, Carcinoma/*therapy , Prostatic Neoplasms/*therapy, Algorithms ; Carcinoma/diagnosis ; Carcinoma/pathology ; Humans ; Male ; Medical Oncology/legislation & jurisprudence ; Neoplasm Metastasis ; Neoplasm Staging/methods ; Orchiectomy/statistics & numerical data ; Prostatectomy/statistics & numerical data ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Spain ; Treatment Failure